Survivin与肿瘤的关系

被引:9
作者
杜冠辉 [1 ]
谭金凤 [2 ]
吴淑金 [1 ]
李强 [1 ]
机构
[1] 广东省医学情报研究所《实用医学杂志》编辑部
[2] 中山大学附属第一医院妇产科
关键词
Survivin; 肿瘤; 细胞凋亡; 细胞周期; 抗肿瘤药;
D O I
暂无
中图分类号
R730.2 [肿瘤病理学、病因学]; R730.5 [肿瘤治疗学];
学科分类号
100214 ;
摘要
Survivin是凋亡抑制蛋白家族成员之一,在细胞凋亡和分化中扮演着重要角色,对细胞周期起调控作用。人类胚胎和大多数肿瘤细胞中均有survivin的表达,但在正常分化成熟的细胞中却极少。许多抗肿瘤药物通过诱导细胞凋亡而发挥抗肿瘤作用,但某些肿瘤表现出对它们的抗药性。导致肿瘤抗药性的一个最重要的因素就是survivin的表达。有关细胞凋亡途径和survivin表达方面的研究可提供发现和发展新型抗肿瘤药的新途径。
引用
收藏
页码:658 / 660
页数:3
相关论文
共 7 条
[1]  
Histopathological prognostic factors in medulloblastoma: High expression of survivin is related to unfavourable outcome[J] . C. Haberler,I. Slavc,T. Czech,E. Gelpi,H. Heinzl,H. Budka,C. Urban,M. Scarpatetti,G. Ebetsberger-Dachs,C. Schindler,N. Jones,A. Klein-Franke,H. Maier,B. Jauk,A. Kiefer,J.A. Hainfellner.European Journal of Cancer . 2006 (17)
[2]  
Expression and antigenicity of survivin, an inhibitor of apoptosis family member, in bladder cancer: Implications for specific immunotherapy[J] . Hiroshi Kitamura,Toshihiko Torigoe,Ichiya Honma,Hiroko Asanuma,Emiri Nakazawa,Kumiko Shimozawa,Yoshihiko Hirohashi,Eiji Sato,Noriyuki Sato,Taiji Tsukamoto.Urology . 2006 (5)
[3]   Nuclear interaction of Smac/DIABLO with Survivin at G2/M arrest prompts docetaxel-induced apoptosis in DU145 prostate cancer cells [J].
Kim, Ji Young ;
Chung, Jin-Yong ;
Lee, Seung Gee ;
Kim, Yoon-Jae ;
Park, Ji-Eun ;
Yoo, Ki Soo ;
Yoo, Young Hyun ;
Park, Young Chul ;
Kim, Byeong Gee ;
Kim, Jong-Min .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2006, 350 (04) :949-954
[4]   Effect of downregulation of survivin expression on radiosensitivity of human epidermoid carcinoma cells [J].
Sah, Nand K. ;
Munshi, Anupama ;
Hobbs, Marvette ;
Carter, Bing Z. ;
Andreeff, Michael ;
Meyn, Raymond E. .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2006, 66 (03) :852-859
[5]   Survivin downregulation by siRNA sensitizes human hepatoma cells to TRAIL-induced apoptosis [J].
Nakao, Kazuhiko ;
Hamasaki, Keisuke ;
Ichikawa, Tatsuki ;
Arima, Kazuhiko ;
Eguchi, Katsumi ;
Ishii, Nobuko .
ONCOLOGY REPORTS, 2006, 16 (02) :389-392
[6]  
High survivin predicts a poor response to endocrine therapy, but a good response to chemotherapy in advanced breast cancer[J] . Paul N. Span,Vivianne C.G. Tjan-Heijnen,Peggy Manders,Doorlene Tienoven,Jeffrey Lehr,Fred C.G.J. Sweep.Breast Cancer Research and Treatment . 2006 (2)
[7]  
Expression of survivin, platelet-derived growth factor A (PDGF-A) and PDGF receptor α in primary central nervous system lymphoma[J] . K. Karabatsou,P. Pal,S. Dodd,B. Haylock,M. Aguirreburualde,N. Moxam,W. Pinson-Ellis,J. Broome,N.G. Rainov.Journal of Neuro-Oncology . 2006 (2)